Bruce Aronow, PhD
College of Medicine - UC
Molecular Biology and Cancer Genetics
As a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, Bruce Aronow, PhD, works with investigators in diverse areas to use technologies that measure gene activity, variation and mutation across the genome. He is based at Cincinnati Children’s Hospital Medical Center.
His team’s research is devoted to the development of databases and the analysis of experimental and clinical data to help researchers predict active pathways of cancer based on gene expression, gene mutation, and biological function analyses. His recent work includes development of a new database that profiles drug sensitivities of different cancers to help predict the most powerful therapeutic agents against different cancers and provides the research community with tools to rank genes, mutations, pathways, and regulatory mechanisms for their role in normal, disease and oncogenic processes and functions.
In just the past three years, Dr. Aronow has co-authored more than 50 papers to share his research in well-respected publications, including Nature, Lancet, Science Translational Medicine, Journal of Clinical Investigation and Nature Biotechnology.